Back to Search
Start Over
Abnormal metaphase cytogenetics predicts venous thromboembolism in myeloma: derivation and validation of the PRISM score
- Source :
- Blood; December 2022, Vol. 140 Issue: 23 p2443-2450, 8p
- Publication Year :
- 2022
-
Abstract
- •Abnormal metaphase cytogenetics is a predictor of VTE within 12 months in newly diagnosed myeloma.•The PRISM score can identify patients at a high risk of VTE in clinical practice and for designing thromboprophylaxis trials in myeloma.
Details
- Language :
- English
- ISSN :
- 00064971 and 15280020
- Volume :
- 140
- Issue :
- 23
- Database :
- Supplemental Index
- Journal :
- Blood
- Publication Type :
- Periodical
- Accession number :
- ejs61320732
- Full Text :
- https://doi.org/10.1182/blood.2022015727